BRIEF-Aldeyra Therapeutics Announces Achievement Of Primary Endpoint Of Ocular Redness In Mid-Stage Study In Dry Eye Disease
Reuters
2021-11-02 20:06
Aldeyra Therapeutics
-7.47%
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论

暂无评论
BRIEF-Aldeyra Therapeutics Announces Achievement Of Primary Endpoint Of Ocular Redness In Mid-Stage Study In Dry Eye Disease
Reuters
2021-11-02 20:06
Aldeyra Therapeutics
-7.47%
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。